L02AB Progestogens, endocrine therapy drugs
ATC group of level 4 – chemical subgroup · in plain English: hormone treatment of cancer
This site has the patient leaflet or the SPC of 13 medicines in this group and its subgroups.
- 12 prescription only (POM)
- 1 no longer supplied or not available
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L02 Endocrine therapy antineoplastic and immunomodulating agents 131 medicines
- L02A Hormones and related agents 44 medicines
-
L02AB Progestogens, endocrine therapy drugs 13 medicines
- L02AB01 megestrol 2 medicines
- L02AB02 medroxyprogesterone 11 medicines
-
L02AB Progestogens, endocrine therapy drugs 13 medicines
- L02A Hormones and related agents 44 medicines
- L02 Endocrine therapy antineoplastic and immunomodulating agents 131 medicines
1 more subgroup has no medicine with a leaflet on this site.
Active substances in the group
- Medroxyprogesterone 11 medicines
- Megestrol 2 medicines
Medicines in the group and its subgroups
Other groups of the same level
Other names of the ATC group
- Czech: L02AB Progestiny
- French: L02AB progestatifs
- German: L02AB Gestagene
- Spanish: L02AB PROGESTAGENOS (TERAPIA ENDOCRINA)
- German: L02AB Gestagene
- Italian: L02AB PROGESTINICI
- Polish: L02AB Progestageny
- Turkish: L02AB Progestojenler, endokrin tedavi ilaçları
- Portuguese (Brazil): L02AB Progestagénios
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L02AB
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
